NK cell-based immunotherapy

Keyphrases

• Cell-based 100%
• Natural Killer Cells 100%
• Solid Tumors 50%
• Chemotherapy 50%
• Radiotherapy 50%
• T Cells 50%
• Transformed Cells 50%
• Low Dose Rate 50%
• Umbilical Cord Blood 50%
• Cancer Immunotherapy 50%
• Allogeneic 50%
• Graft-versus-host Disease (GvHD) 50%
• Neurotoxicity 50%
• Allogeneic Cells 50%
• Activating Receptors 50%
• Adaptive NK Cells 50%
• Rational Combinations 50%
• Disease Incidence 50%
• Ex Vivo Expansion 50%
• Induced Pluripotent Stem Cells (iPSCs) 50%
• In Vivo Activity 50%
• Small Molecule Kinase Inhibitors 50%
• Inhibitory Receptors 50%
• Engager 50%
• NK Cell Therapy 50%
• Integrated Signal 50%
• Checkpoint Inhibitors 50%
• Multi-antigen 50%
• Safety Switch 50%
• Metabolic Rewiring 50%
• Transcriptional Rewiring 50%
• Cytokine Release Syndrome 50%
• Logic-gated CAR 50%
• CAR Engineering 50%

Immunology and Microbiology

• Immunotherapy 100%
• Natural Killer Cell 100%
• T Cell 20%
• Transformed Cell 20%
• Cytokine 20%
• Umbilical Cord Blood 20%
• Cancer Immunotherapy 20%
• Graft-Versus-Host Disease 20%
• Induced Pluripotent Stem Cell 20%
• Cytokine Release Syndrome 20%
• Phosphotransferase 20%
• Kinase 20%